# Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)

> **NCT00856661** · PHASE3 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 270 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Desmoteplase
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00856661
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2014-10
- **Final completion:** —
- **Target enrollment:** 270 (ACTUAL)
- **Why stopped:** The recruitment into DIAS4 has been stopped as the result of DIAS 3 indicates that the study is unlikely to reach its primary endpoint with the current protocol
- **Last updated:** 2017-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856661, "Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00856661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*